Oxidative DNA damage and embryo development.
Eriksson
U J
UJ
D000014:Abnormalities, Drug-Induced / Q000517:prevention & control; D000818:Animals; D000975:Antioxidants / Q000627:therapeutic use; D004249:DNA Damage; D005314:Embryonic and Fetal Development / Q000187:drug effects; D005260:Female; D006801:Humans; D006993:Hypnotics and Sedatives / Q000009:adverse effects / Q000633:toxicity; D011247:Pregnancy; D011254:Pregnancy in Diabetics; D011817:Rabbits; D017382:Reactive Oxygen Species / Q000502:physiology*; D013792:Thalidomide / Q000009:adverse effects / Q000493:pharmacokinetics / Q000633:toxicity
D000975:Antioxidants; D006993:Hypnotics and Sedatives; D017382:Reactive Oxygen Species; D013792:Thalidomide